Long-term Pegvisomant Therapy of Acromegaly: Effects on Bone Density, Turnover and Microstructure Using HRpQCT.

J Endocr Soc · 2024 · PMC11074588 · PMID 38715589

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

showed a trendP = .01actually significant

PTH showed a trend to increase early, by 4 weeks, after the start of pegvisomant but was only significantly higher compared to pretreatment at 24 weeks of therapy ( P = .01). 25-hyroxy vitamin D levels also tended to increase early after the start of pegvisomant and were significantly higher than pretreatment at 8 ( P = .05) and 12( P = .01) weeks of therapy.

also in 10,348 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.